David Guyer News Today

Just now coming to light . And giants drama. 25 years to the day after an earthquake struck San Francisco during the world series. More drama. Hits one into right. The giants win. As the giants head back to the fall classic today, friday, october 17th, 2014. From nbc news, this is today. With matt lauer and savannah guthrie, live from studio 1a in rockefeller plaza. And the giants win, the giants win. Welcome to today on a friday morning, im matt lauer along with natalie, al, and tam ran. Savann...

Positive for cocaine. He is apologizing but why is it now just coming to light . Decades after earthquake struck San Francisco during the world series, more drama. Ishikawa hits one into right the giants win the pennant. As the giants head back to the fall classic today, friday, october 17th, 2014. Announcer from nbc news, this is today with matt lauer and savannah guthrie, live from studio 1a in rockefeller plaza. And the giants win the pennant the giants win the pennant. Welcome back to a frid...

EyeBio chairman Dame Kate Bingham (pictured) led Britains Covid vaccine task force in early 2020 and is the chairman of EyeBio.

Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held ophthalmology-focused biotech firm, in a deal valued up to $3 billion....

In addition to augmenting Merck’s pipeline, the company said, the acquisition significantly expands the company’s presence in ophthalmology.

London-based biotech company EyeBio, co-founded by Dame Kate Bingham, sold to Merck for up to $3bn, promising revolutionary treatments for blindness.

The privately held ophthalmology-focused biotechnology company focuses on the treatment of vision loss associated with retinal vascular leakage.

By scooping up EyeBio, Merck is expanding its ophthalmology offerings and bolstering its vision care pipeline.

BioPharma

Merck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech.